| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/28/2007 | CN1935156A Remedy |
| 03/28/2007 | CN1935155A Remedy |
| 03/28/2007 | CN1935141A Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 03/28/2007 | CN1935133A Human leucocyte antigen DR4 subtype protein agonist |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307179C Pyrimidine derivatives for inhibition of cell proliferation |
| 03/28/2007 | CN1307176C Novel alkoxypyridine-derivatives |
| 03/28/2007 | CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307159C TNF-alpha prodn. inhibitors |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/28/2007 | CN1307157C Novel compounds |
| 03/28/2007 | CN1307150C Hydroxy tetrahydro-naphthalenylurea derivatives |
| 03/28/2007 | CN1307147C 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 03/28/2007 | CN1306964C Decoy composition for treating and preventing inflammatory disease |
| 03/28/2007 | CN1306949C Compound Chinese medicine formulation for tendon relaxation and anti-dampness, and its preparing method |
| 03/28/2007 | CN1306941C Skin preparation for external use containing purpuricenus temminckii frass as the active ingredient |
| 03/27/2007 | USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196175 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/27/2007 | US7196099 Compounds and compositions as cathepsin inhibitors |
| 03/27/2007 | US7196097 MAP kinase inhibitors; treating arthritis, ankylosing spondylitis, psoriatic arthritis, various gastrointestinal disorders; adult respiratory distress syndrome, asthma, COPD and Alzheimer's disease. |
| 03/27/2007 | US7196095 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 03/27/2007 | US7196092 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/27/2007 | US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | US7196078 Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/27/2007 | US7196077 Tachykinin antagonists |
| 03/27/2007 | US7196071 Methods of decreasing or preventing pain using spicamycin derivatives |
| 03/27/2007 | US7195906 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195886 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 03/27/2007 | US7195870 Diagnosis of diseases associated with gene regulation |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 03/27/2007 | CA2399976C Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 03/27/2007 | CA2391953C Nervonic acid derivatives, their preparation and use |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/27/2007 | CA2247520C Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
| 03/27/2007 | CA2200084C Use of aromatic halides for treating mammalian cell proliferation |
| 03/27/2007 | CA2134966C Antibodies with specificity for multiple adhesion molecules |
| 03/22/2007 | WO2007033232A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/22/2007 | WO2007032561A1 Novel inhibitor of vascular endothelial growth factor expression |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2007032445A1 Protein kinase inhibitors |
| 03/22/2007 | WO2007031996A1 Compositions and methods for diagnosing and treating an inflammation |
| 03/22/2007 | WO2007030939A2 Methods of modulating neurotrophin-mediated activity |
| 03/22/2007 | WO2006134385A3 Anti-inflammatory agents |
| 03/22/2007 | WO2006122786A3 Improved nanobodies™ against tumor necrosis factor-alpha |
| 03/22/2007 | WO2006119958A3 Use of flibanserin in the treatment of chronic pain |
| 03/22/2007 | WO2006030217A3 Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs |
| 03/22/2007 | WO2005054264A3 Glycomimetic antagonists for both e- and p-selectins |
| 03/22/2007 | US20070067856 Therapeutic agent for NGF |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066645 Novel compounds |
| 03/22/2007 | US20070066640 Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066607 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors |
| 03/22/2007 | US20070066586 Aniline derivatives |
| 03/22/2007 | US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 03/22/2007 | US20070066576 Compounds which modulate 2OG (2-oxoglutarate) dependent oxygenases, in particular prolyl hydroxylases; may be useful as modulators of HIF (hypoxia inducible factor) alpha (HIF- alpha ) prolyl hydroxylase; for example, analogues of 2-oxoglutarate, N-phenoxy-acetyl-(L)-alanine-hydroxamide |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/22/2007 | US20070066564 Sulfotransferase inhibitor |
| 03/22/2007 | US20070066555 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065493 External patch containing estrogen and/or progestogen |
| 03/22/2007 | US20070065485 Therapeutic delivery of carbon monoxide |
| 03/22/2007 | US20070065445 Novel cyclooxygenase variants and methods of use |
| 03/22/2007 | US20070065435 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065434 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | CA2622725A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2622571A1 Methods of modulating neurotrophin-mediated activity |
| 03/22/2007 | CA2621983A1 Azafused cyclin dependent kinase inhibitors |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/22/2007 | CA2621270A1 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation |
| 03/22/2007 | CA2621248A1 Anti-human sr-b1 antibody reducing inflammation and treating auto-immunedisease |
| 03/22/2007 | CA2606727A1 Lipid a analogs for treating oral and gastrointestinal mucositis |
| 03/21/2007 | EP1764367A1 Thienopyridine derivatives |
| 03/21/2007 | EP1764366A2 Thrombin receptor antagonists |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764106A2 Use of insulin-like growth factor I for the inhibition of ischemic injury involving the liver |
| 03/21/2007 | EP1764096A1 Novel phloroglucinol derivatives having selectin ligand activity |
| 03/21/2007 | EP1764095A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 03/21/2007 | EP1764085A1 Cosmetic composition comprising argan oil |
| 03/21/2007 | EP1763528A1 Pyrazolopyridine derivatives |
| 03/21/2007 | EP1763509A1 Alpha-helical mimetics |
| 03/21/2007 | EP1763507A2 Alpha-amino acid derivates with antiinflammatory activity |
| 03/21/2007 | EP1763370A1 Formulations comprising a capsaicinoid, a local anesthetic and/or an antipruritic agent for the treatment of pain |
| 03/21/2007 | EP1763361A2 Steroid sparing agents and their use |
| 03/21/2007 | EP1763351A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 03/21/2007 | EP1763347A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 03/21/2007 | EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases |
| 03/21/2007 | EP1455782B1 High-concentration stable meloxicam solutions for needle-less injection |